Theme: Advancement and impact of Ophthalmologists in Scientific Era

Ophthalmologists 2016

Renowned Speakers

Ophthalmologists 2016

 Conference Series LLC invites all the participants from all over the world to attend 6th Global Ophthalmologists Annual Meeting during May 16-18 2016 in Osaka, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Ophthalmology Surgery:

There are a variety of conditions that may call for eye surgery; from cosmetic changes to vision-saving procedures. Each treatment comes with its own benefits, risks, and indications for use. From corrective treatments to orbital implants, today’s advancements can tackle almost any condition and provide a successful solution.

Related Conferences:

International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conference June 16-18, 2016 Alicante, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA,Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland 

Ophthalmology Practise:

As the world becomes more complex and knowledge in every field becomes more extensive and detailed, it’s increasingly difficult to master everything in any one area. This is certainly true in the field of ophthalmology, which is undoubtedly one of the reasons for the recent trend towards specialization. However, this is only one of many factors contributing to the shift. Today, the multitude of pressures affecting ophthalmologists in general—and comprehensive ophthalmologists in particular has become so oppressive that many doctors wonder whether comprehensive ophthalmology can survive.

Related Conferences:

International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conference June 16-18, 2016 Alicante, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA,Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland 

Retina and Retinal Disorders:

The retina is a thin layer of tissue on the inside back wall of your eye. It contains millions of light-sensitive cells and other nerve cells that receive and organize visual information. Your retina sends this information to your brain through your optic nerve, enabling you to see. Retinal degenerative disorders such as Age-related macular degeneration and myopic macular degeneration affecting young and old from many cultures, races and ethnicities. The central area of the retina contains a high density of colour-sensitive photoreceptor cells called cones which are responsible for color vision and hence any defect and alteration in the central area of the retina will lead to Color vision defects.  On the other hand diseases like Diabetic retinopathy and Retinal tumors can also be responsible for the permanent vision loss if it is not treated on time. Historically, retinal disease has had a low priority in prevention of blindness programs in developing countries. There are several reasons for this. Firstly, it was thought that retinal disease was an uncommon cause of blindness in the developing world; secondly, that the results of treating retinal disease did not justify the effort and expense involved; and, thirdly, that the equipment required was too costly and unreliable for use in a developing country environment. Finally, there is a lack of skilled personnel with sub-specialty training in retinal disease. John Hopkins School of Medicine, UCSF School of Medicine, David Geffen School of Medicine and Mayo Medical School are the leading institute’s associates with ophthalmology.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester; UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision  September 26-28, 2016  Miami, USA;  International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016  Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting  February 27- March 03, 2016 AZ,USA.
 

Glaucoma: Visual Field Loss

Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of vision. The exact pathophysiology of glaucoma contributing to this is yet to be determined. Biomarkers for glaucoma have predictive use that could help and guide more specific therapy in some glaucoma patients. Endothelin in glaucoma treatment play a very key role in pathogenesis of glaucoma. Glaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually. The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada. Bascom Palmer and Wills Eye are the top researcher organization for glaucoma.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy ; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016  Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ,USA; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE
 

Neuro-Ophthalmology:

Neuro-ophthalmology is the incorporation of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Cerebral Visual Impairment (CVI) includes all visual dysfunctions caused by damage to, or malfunctioning of, the retrochiasmatic visual pathways in the absence of damage to the anterior visual pathways or any major ocular disease. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles which leads to double vision, drooping eyelids and other muscles weakness which effecting the both i.e. neuromuscular activity and also vision. On the other hand nystagmus which is involuntary eye movement acquired in infancy or later in life that may result in reduced or limited vision. Factors like cerebral macular degeneration and chronic progressive external ophthalmoplegia also the major effecting part of neuro-ophthalmology. Diagnostic tools in neuro-ophthalmology are used to investigate and to treat the various condition of neuro-ophthalmology as  Neonatal ocular examination are primarily performed to monitor the presence and progression of Retinopathy of Prematurity. University of Pennsylvania is currently working on neuro-ophthalmology project.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016  Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; First Canadian Glaucoma Meeting  April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ, USA; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA
 

Lens Disorders and Refractive Surgery:

A cataract is a clouding of the lens in the eye leading to a decrease in vision. They may affect one or both eyes. Often they develop slowly. Symptoms may include faded colors, blurry vision, halos around light, trouble with bright lights, and trouble seeing at night. This may result in trouble driving, reading, or recognizing faces. Poor vision may also result in an increased risk of falling and depression. Cataracts are the cause of half of blindness and 33% of visual impairment worldwide. Cataracts are most commonly due to aging, but may also occur due to trauma, radiation exposure, be present from birth, or occur following eye surgery for other problems. Risk factors include diabetes, smoking tobacco, prolonged exposure to sunlight, and alcohol. Either clumps of protein or yellow-brown pigment may be deposited in the lens reducing the transmission of light to the retina at the back of the eye. Diagnosis is by an eye exam. A cataract is a clouding of the lens in the eye leading to a decrease in vision. They may affect one or both eyes. Often they develop slowly. Symptoms may include faded colors, blurry vision, halos around light, trouble with bright lights, and trouble seeing at night. This may result in trouble driving, reading, or recognizing faces. Poor vision may also result in an increased risk of falling and depression. Cataracts are the cause of half of blindness and 33% of visual impairment worldwide. Cataracts are most commonly due to aging, but may also occur due to trauma, radiation exposure, be present from birth, or occur following eye surgery for other problems. Risk factors include diabetes, smoking tobacco, prolonged exposure to sunlight, and alcohol. Either clumps of protein or yellow-brown pigment may be deposited in the lens reducing the transmission of light to the retina at the back of the eye. Diagnosis is by an eye exam.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA;  International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting Febuary27-March 03, 2016 AZ, USA; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA
 

Ocular Microbiology and Immunology:

Many of the viruses, bacteria, parasites, and fungi that can invade the human body are also capable of attacking the surface or interior of the eye. The natural tendency for immunologic disease to affect the eye derives from a number of factors such as Antibody-dependent & antibody-mediated diseases, Uveitis, intraocular inflammation and cell-mediated diseases. The immune system plays a critical role during transplantation and as the corneal transplantation has become increasingly common since the 1960s and over 40,000 transplants were performed in 1990 in the United States and Canada. The 5-year failure rate for corneal grafts is approximately 35%; corneal graft rejection is the most common cause of graft failure in the late postoperative period but with the recent development in immunotherapy can be a breakthrough to overcome from all the limitations of the conventional procedures. The microbiological infection such as fungal endophthalmitis can affect the vitreous and anterior chamber of the eye and hence the uses of antibiotic in ocular infections have been increased to overcome these conditions. The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision  September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting Feburary 27-March 03 2016 AZ, USA
 

Research Trends in Surgical and Medical Ophthalmology:

Translational Ophthalmology is a latest trend that bridges the gap by achieving breakthrough discoveries to patients faster than ever. Translational Research is a new initiative of the National Institutes of Health (NIH) which aims to translate basic research into more advanced form to yield the better results. The research trend discoveries maximize the opportunities to investigate the issues very minutely to decrease the risk of failure especially during surgical procedure like cataract and refractive surgery. Many fruitful facts have been discovered which indirectly helps in treating the respective conditions such as Age-Related Eye Disease Study (AREDS) proved that nutritional supplements (nutrition and ophthalmology) could minimize the risk of AMD. The American Health Assistance Foundation, dedicated to eradicating age-related degenerative diseases, estimates that up to 11 million people in the United States have some form of AMD - a number expected to double by 2050. Estimates of the global cost of visual impairment AMD causes are $343 billion, including $255 billion in direct health care costs, according to the foundation. Ophthalmology represents 18 percent of the average case volume in surgery centers, second behind GI/endoscopy (25 percent). The average surgery center performs 4,869 cases annually, which would average to around 876 ophthalmology cases annually, according to VMG Health's 2009 Intellimarker.

Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ,USA
 

Ophthalmic Research on Drug Development:

Advances in ophthalmic drug delivery systems such as Punctal Plugs, Ocular Therapeutix, Mati therapeutics (QLT) and gel-forming drops can be breakthrough in ophthalmic research and advance drug delivery system to maximize the therapeutic effect of a particular drug. Topical combination of corticosteroid & anti-infective agents, Drugs used in the treatment of allergic conjunctivitis, Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs) and Retinoblastoma chemotherapy are few developed formulation to treat ophthalmic diseases. Companies like Allergan, Pfizer, Bausch + Lomb, Merck & Co. and Regeneron are actively participated in ophthalmic research and drug development. According to visiongain (Ophthalmic Drugs: World Market Prospects - 2013-2023; October 2013), the worldwide ophthalmic market was $17.5 billion in 2011 and is expected to grow to $34.7 billion by 2023, representing a 5.9% compounded annual growth rate.

Related Conferences:
8thGlobal Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ, USA
 

Ophthalmology Instruments:

An understanding of the commonly used ophthalmic instruments is essential for any practising ophthalmologists. Ophthalmic instruments according to procedures:

cataract extraction (phaco) glaucoma
squint corneal graft
retinal detachment ptosis
dacryocystorhinostomy lid surgery
enucleation / evisceration chalazion
Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision  September 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February27-March 03 2016 AZ, USA
 
 
The role of financial investment both personally and for an ophthalmic practice.The fundamentals of excellent customer/patient relationship management.Establishing an effective insurance strategy to preserve income and a family future.Case study on EHR system selection, adoption, implementation, and adjustment.Tangential uses of EHR systems to increase practice revenue.Utilizing effective communication skills to create greater efficiencies within a practice.Practical tax tips to preserve revenue and income.
 
Related Conferences:
8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery Aug 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2nd International Conference on Eye and Vision Sept 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; 9th World Ophthalmic Conference October 24-26, 2016  Istanbul, Turkey; 10th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada. USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016  Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting  February 27-March 03 2016 AZ, USA

 

Ophthalmologists, optometrists and opticians all provide eye care services. It is important to understand what each of the "three Os" is qualified to do.

Ophthalmologists
An ophthalmologist is a physician (doctor of medicine, MD, or doctor of osteopathy, DO) who specializes in the medical and surgical care of the eyes and visual system and in the prevention of eye disease and injury. An ophthalmologist has completed four or more years of college premedical education, four or more years of medical school, one year of internship and three or more years of specialized medical and surgical and refractive training and experience in eye care. An ophthalmologist is a specialist who is qualified by lengthy medical education, training and experience to diagnose, treat and manage all eye and visual systems and is licensed by a state regulatory board to practice medicine and surgery. An ophthalmologist is a medically trained specialist who can deliver total eye care: primary, secondary and tertiary (i.e., vision services, contact lenses, eye examinations, medical eye care and surgical eye care), diagnose general diseases of the body and treat ocular manifestations of systemic diseases.

Optometrists
An optometrist is a health service provider who is involved primarily with vision problems. Optometrists are specifically educated and trained by an accredited optometry college in a four year course, but have not attended medical school. They are state licensed to examine the eyes and to determine the presence of vision problems. Optometrists determine visual acuity and prescribe spectacles, contact lenses and eye exercises. Optometrists may perform all services listed under the definition of an optician. Some states permit optometrists to give limited treatments of some eye conditions. 

Opticians
An optician is a technician who makes, verifies and delivers lenses, frames and other specially fabricated optical devices and/or contact lenses upon prescription to the intended wearer. The opticians' functions include prescription analysis and interpretation; determination of the lens forms best suited to the wearers needs; the preparation and delivery of work orders for the grinding of lenses and the fabrication of eye wear, the verification of the finished ophthalmic products; and the adjustment, replacement, REPAIR and reproduction of previously prepared ophthalmic lenses, frames and other specially fabricated ophthalmic devices. 

The 6th Global Ophthalmologists Annual Meeting which is going to be held during May 16-18, 2016 at Osaka Japan which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. Ophthalmologists 2016 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Cornea and External Eye Disease, Retina and Retinal Disorders, Neuro-Ophthalmology, Glaucoma: Visual Field Loss, Ocular Microbiology and Immunology, Novel Approaches to Ophthalmology Therapeutics and many more. ophthalmology Conferences 2016, ophthalmologists Summit, ophthalmology Conferences Asia, ophthalmology events, ophthalmologists meetings, ophthalmologist Congress, eye disorders Conferences, glaucoma Summit, cataract Congress, ophthalmology Conference.

Ophthalmology Conferences, Events, Meetings, Japan, AAO 2016, Conference Series LLC

Meet significant Ophthalmologists, Optometrists Researchers Clinicians from Japan Osaka Hong Kong Germany Singapore Saudi Arabia China Spain Taiwan Chicago UK Korea India Australia and many more countries.

OMICS International Organizes 300+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Retinal disorders, optic atrophy, and lesions of the higher visual pathways are the main anatomical causes of visual loss in children. WHO reports that, 285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision. About 90% of the world’s visually impaired live in low-income settings 82% of people living with blindness are aged 50 and above. Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries. Many European associations are involved in Ophthalmology and many eye banks are actively promoting the donation of eyes in Europe, addressing a gap in the ophthalmic market, the global ophthalmic market was valued at $10.3 billion in 2010 and is estimated to reach $13.2 billion in 2017.

 

Overall market trend of ophthalmology:

After a huge downfall of the market during economic drain in 2008-2009, ophthalmology market is catching up to get back to the normal as there is a rapid growth in population resulting in increased number of patients with eye diseases. And the incidence of cataract and glaucoma are increasing every year.

According to a study it is estimated that around 48% of world population is blind because of cataract and more than 60 million people suffer from glaucoma and it is estimated that the number would rise to 80 million by the end of 2020. Ageing population is the leading cause for refractive error problem in countries like the USA and Europe, it is noticed that the refractive error problem is mostly seen in population ageing more than 40 years.

Ophthalmology market is mainly divided in to four segments viz, surgical devices, diagnostic and monitoring devices, vision care and ophthalmic drugs.

Importance and scope:

  Ophthalmologists 2016 enhances ophthalmic education to improve eye care Institutes like (NIE, Wilmer are involved) Contribute to preservation and restoration of vision around the world.

Cataract removal is the most commonly performed ophthalmic surgical operation.

Ophthalmology continues to be an attractive field of medicine with great opportunities.

WHO reports that

•285 million people are estimated to be visually impaired worldwide: 39 million are blind and 246 have low vision.

•About 90% of the world’s visually impaired live in low-income settings.

•82% of people living with blindness are aged 50 and above.

•Globally, uncorrected refractive errors are the main cause of moderate and severe visual impairment; cataracts remain the leading cause of blindness in middle- and low-income countries.

•The number of people visually impaired from infectious diseases has reduced in the last 20 years according to global estimates work.

•80% of all visual impairment can be prevented or cured.

Why in Japan:

In addition to being the fastest growing market for pharmaceuticals, accessible patient populations and the growing infrastructure for quality conduct of clinical trial makes Japan attractive for global clinical development and a need for local regulatory authorities to quickly bring their processes and guidelines up to date and in alignment with the changing clinical trial environment in each country has emerged. Efforts toward regulatory collaboration to bridge the gap between different countries’ requirements are underway. This has led to a certain degree of convergence for regulatory principles and pathways while implementing local regulatory changes in a way that is compatible with local environments.

And more over Japan tourism attracts more than 8 million people every year from around the world, which has more than 16 world heritage sites. And statistics shows that the highest % of people visiting Japan are not just from Asian countries but also from  all around the world, this makes Japan a most preferable destination for the Ophthalmologists 2016 conference.

Members associated with ophthalmology research:

 

According to the statistics provided by International Council of Ophthalmology (ICO) the number of people who are associated with ophthalmology research are >35,>5500and >120000 in Osaka, Japan and Rest of the World (RoW) respectively.

Hospitals associated with ophthalmology:

 

Number of hospitals associated with ophthalmology research in Osaka are only 2, they are Osaka university hospital and Osaka state university hospital, and there are approximately around 60 hospitals associated with ophthalmology research in Japan.. And in the rest of world there are around 700 hospitals (app) associated with ophthalmology research..

Major hospitals associated with ophthalmology around the world are:

  • Johns Hopkins School of Medicine
  • UCSF School of Medicine
  • David Geffen School of Medicine
  • Mayo Medical School
  • LV Prasad eye institute.

Societies associated with ophthalmology:

 

According to the statistics provided by ICO there are only two societies associated with ophthalmology in Osaka and four in Japan and more than 5000 in RoW.

Major societies associated with ophthalmology are:

  • American Academy of Ophthalmology (AAO)
  • American Association for Paediatric Ophthalmology and Strabismus
  • Asia Pacific Glaucoma Society
  • Association for Research in Vision and Ophthalmology

Major societies in Asia pacific region:

  • Asia pacific academy of ophthalmology
  • Asia pacific association of refractive cataract surgeons
  • Asia pacific glaucoma society
  • Asia pacific vitreoretina society
  • Japanese ophthalmological   society

Industries associated with ophthalmology:

  •  

When it comes to ophthalmology industries USA leads the market followed by Japan. Some of the leading companies in ophthalmology market are listed below:

  • Alcon (Novartis)(USA)
  • Abbott Medical Optics (Abbott)(USA)
  • Bausch and Lomb (Valeant Pharmaceuticals)(Canada)
  • Johnson and Johnson Vision Care (Johnson and Johnson)(USA)
  • Nidek(Japan)
  • Topcon Corporation(Japan)
  • Carl Zeiss AG Meditec(Germany)

Universities associated with ophthalmology:

 

Glance at Market of Advertising and Marketing:

Changing trends in diet and lifestyle as well as increased long life are growing the market for ophthalmological treatments: the global ophthalmic device market is expected to reach $28 billion by 2016 exhibiting a 2.5% compound annual growth rate from 2009 to 2016, according to GBI Research.

“The worldwide ophthalmic products market beats $22 billion (US) and is rising at more than 10% per year. Without the supplement of consumer eye care products, the ophthalmic products market is coarsely a $17 billion market.” Rising of call for ophthalmic devices and increasing healthcare coverage in emerging economies will rise sales to 2024.The medical device market of Japan is mainly comprised of medical equipment’s such as consumables, orthopaedic devices, dental devices, respiratory devices, and ophthalmic devices which are manufactured in Germany, France, the UK, Italy and Spain. The demand for medical devices has been increasing owing to a growing awareness for early diagnosis and treatment of uncountable disease states in Japan. The key countries that have contributed significantly in developing medical devices market during 2008-2013 include Germany, UK, Spain and France. Germany is one of the chief medical instrument development markets and it has been observed that the country contributes immensely to the exports of medical devices.  

 

The rise in growth curve in revenue of ophthalmic instruments and drugs will not only be seen in developed countries ,but also in developing countries like India,China,Brazil,South Korea  and  Russia in particular will see equally high revenue growth by 2024.

Statistics of Physicians, Researchers and Academicians working on ophthalmology:

 

According to the statistics provided by ICO there are app 60-70 ophthalmologists in Osaka and more than 13000 ophthalmologists in Japan and app.200000 ophthalmologists worldwide. Among them 60% of ophthalmologist are into surgery and in Japan alone 50% of ophthalmologists are into surgery and around 1000 ophthalmologists are residents.

References:

http://www.nichigan.or.jp/english/hospital.jsp

https://en.wikipedia.org/wiki/List_of_university_hospitals

http://www.icoph.org/ophthalmologists-worldwide.html

http://www.prnewswire.com/news-releases/ophthalmic-devices-market-forecast-2014-2024-future-prospects-for-leading-companies-271870351.html

 

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 16-18, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2 Day 3
Poster Opportunity Closed Click Here to View